78.1 F
New York
Saturday, August 20, 2022



Aatru Medical Announces FDA Clearance and Commercial Launch of the NPSIMS™ – Negative Pressure Surgical Incision Management System

Related Articles

Pharma CI Conference Returns Next Month: Meet Hundreds of Industry Leaders at the Top Event for 15+ Years

Newark, NJ, August 18, 2022 --(PR.com)-- Ready, set, engage! The Pharma CI USA Conference & Exhibition is back in person and ready to deliver the...

Gilgal Medical Supplies Launches Wholesale Medical Supplies Distribution

Orlando, FL, August 17, 2022 --(PR.com)-- Gilgal Medical Supplies is launching wholesale distribution of medical supplies and equipment sin North America. Gilgal Medical has been...
Cleveland, OH, August 24, 2021 –(PR.com)– Aatru Medical, LLC (“Aatru”) today announced U.S. Food and Drug Administration (FDA) 510(k) Class II clearance of the NPSIMS™ Negative Pressure Surgical Incision Management System.

The NPSIMS utilizes an innovative mode-of-action that eliminates the expensive electro-mechanical pump, battery, and electronics found in most other negative pressure wound therapy (NPWT) systems being deployed for closed surgical incision applications. The single-use, disposable NPSIMS is easily activated and operates silently during therapy delivery. A patented preassembled dressing provides ease-of-application with exceptional “sealing” capability while providing patient comfort and ergonometric appeal.

The FDA effort was led by Aatru President and Board member Edward Armstrong who leveraged his extensive professional prior experience with NPWT and medical device companies. “This innovative NPWT technology…

Read more…

Popular Articles